학술논문
Combination therapy with natural type human tumor necrosis factor (MHR-24) and human lymphoblastoid interferon-α (MOR-22) against renal cell carcinoma. A multiclinic cooperative, early phase II study
Document Type
Article
Author
Source
In: Acta Urologica Japonica . (Acta Urologica Japonica, 1992, 38(10):1201-1207)
Subject
Language
English
ISSN
00181994